Dr. Wagner on the Standard of Care in Angiosarcoma

Video

Michael J. Wagner, MD, discusses the standard of care for patients with angiosarcoma.

Michael J. Wagner, MD, assistant professor, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, discusses the standard of care for patients with angiosarcoma.

There is no established standard of care for angiosarcoma, according to Wagner. Part of the problem is that it is difficult to conduct large clinical trials with such a small patient population, Wagner says.

If the patient is eligible for surgery, angiosarcoma should be removed, Wagner adds. Chemoradiation is often administered, especially for patients with localized disease. Chemotherapy or targeted agents may be an option for those with metastatic angiosarcoma, Wagner concludes.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD